Ipsen Pharma, S. A. S.
Ipsen Pharma, S. A. S. Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20130331324 | USE OF MELANOCORTINS TO TREAT DYSLIPIDEMIA - The present invention relates to peptide ligands of the melanocortin receptors, in particular the melanocortin-4 receptor, and as such, are useful in the treatment of dyslipidemia and associated complications such as alcoholic and non-alcoholic fatty liver disease. | 12-12-2013 |